article thumbnail

Study shows estrogen blocker treatment does not increase risk of coronary heart disease in breast cancer patients

Medical Xpress - Cardiology

New evidence shows that extended estrogen suppression treatment using aromatase inhibitors for hormone receptor-positive postmenopausal breast cancer is safe; it does not increase the risk of coronary artery calcification, a sign of active coronary atherosclerosis, as some prior studies had indicated.

Cancer 119
article thumbnail

Clogged arteries worsened by cells that behave like cancer cells

Science Daily - Heart Disease

Researchers have found that cells inside clogged arteries have cancer-like properties that aggravate atherosclerosis, and anticancer drugs could be a new treatment.

Cancer 105
article thumbnail

Advancing the CV Care of the Oncology Patient: Atherosclerosis, CV Risk Factors Common at Lung Cancer Diagnosis

American College of Cardiology

Nearly 80% of patients with lung cancer had detectable atherosclerosis on their cancer staging CT scans and other cardiovascular risk factors were common, offering an opportunity for earlier cardiac testing and risk factor modification, according to a new study.

article thumbnail

In Women, History of Cancer Linked to Subclinical Atherosclerosis

HCPLive

Sara Diaz Savaria, MD, discusses a study from ESC Congress 2024 examining the utility of cancer history in women as a predictor of subclinical atherosclerosis.

article thumbnail

Scientists find cancer-like features in atherosclerosis, spurring opportunity for new treatment approaches

Science Daily - Heart Disease

Researchers have discovered that the smooth muscle cells that line the arteries of people with atherosclerosis can change into new cell types and develop traits similar to cancer that worsen the disease.

article thumbnail

Comprehensive CT scans may help identify atherosclerosis among lung cancer patients

Medical Xpress - Cardiology

Several cardiovascular risk factors, such as advanced age and smoking history, are prevalent among lung cancer patients at the time of the diagnosis and increase their risk of future heart disease, according to a new study being presented at ACC's Advancing the Cardiovascular Care of the Oncology Patient course.

Cancer 52
article thumbnail

HeartLung.AI Tool Receives 'FDA Breakthrough' AI Clearance

DAIC

30, 2024 — HeartLung Technologies , a developer of AI tools for early detection of heart disease, lung cancer and other conditions announced that its AI-enabled Automated Cardiac Chambers Volumetry (AutoChamber) recently received “Breakthrough Medical Device” designation and marketing authorization from the U.S. added Dr. Naghavi.

Cancer 45